DE69629610D1 - Affinitätsgebunden Collagenmatrizen für Wirkstoffabgabe - Google Patents

Affinitätsgebunden Collagenmatrizen für Wirkstoffabgabe

Info

Publication number
DE69629610D1
DE69629610D1 DE69629610T DE69629610T DE69629610D1 DE 69629610 D1 DE69629610 D1 DE 69629610D1 DE 69629610 T DE69629610 T DE 69629610T DE 69629610 T DE69629610 T DE 69629610T DE 69629610 D1 DE69629610 D1 DE 69629610D1
Authority
DE
Germany
Prior art keywords
matrices
affinity
drug delivery
collagen
affinity bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629610T
Other languages
English (en)
Inventor
Jacqueline A Schroeder
Hanne Bentz
Trudy D Estridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biomaterials Corp
Original Assignee
Cohesion Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cohesion Technologies Inc filed Critical Cohesion Technologies Inc
Application granted granted Critical
Publication of DE69629610D1 publication Critical patent/DE69629610D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69629610T 1995-03-16 1996-02-16 Affinitätsgebunden Collagenmatrizen für Wirkstoffabgabe Expired - Lifetime DE69629610D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/405,320 US5693341A (en) 1995-03-16 1995-03-16 Affinity bound collagen matrices for the delivery of biologically active agents

Publications (1)

Publication Number Publication Date
DE69629610D1 true DE69629610D1 (de) 2003-10-02

Family

ID=23603193

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629610T Expired - Lifetime DE69629610D1 (de) 1995-03-16 1996-02-16 Affinitätsgebunden Collagenmatrizen für Wirkstoffabgabe

Country Status (6)

Country Link
US (1) US5693341A (de)
EP (1) EP0732105B1 (de)
JP (1) JPH08253429A (de)
AT (1) ATE247982T1 (de)
CA (1) CA2165727A1 (de)
DE (1) DE69629610D1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217134A1 (en) * 1996-10-09 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Sustained release formulation
EP1124590B1 (de) 1997-04-03 2009-06-17 California Institute Of Technology Enzym-vermittelte modifizierung von fibrin für gewebeaufbau
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6077987A (en) * 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
CA2340381C (en) * 1998-08-14 2009-01-13 Incept Llc Methods and apparatus for in situ formation of hydrogels
US7601685B2 (en) * 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US6894022B1 (en) * 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7241730B2 (en) * 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
JP2000125872A (ja) 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
MXPA01010692A (es) 1999-04-22 2004-09-06 Univ Zuerich Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada.
CA2369579A1 (en) * 1999-04-22 2000-11-02 Eidgenossische Techninische Hochschule(Eth) Controlled release of growth factors from heparin containing matrices
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
JP2007513083A (ja) * 2003-11-10 2007-05-24 アンジオテック インターナショナル アーゲー 医療用移植片および繊維誘発剤
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
MX2007007732A (es) * 2004-12-22 2007-10-08 Kuros Biosurgery Ag Hidrogeles peg con grupos funcionales para la reaccion de adicion tipo michael con biofactores incorporados con el factor xiiia.
AU2006204461C1 (en) * 2005-01-06 2012-01-12 Baxter Healthcare S.A. Supplemented matrices for the repair of bone fractures
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
PT2136850E (pt) 2007-04-13 2012-04-27 Kuros Biosurgery Ag Selante tecidual polimérico
US9095562B2 (en) * 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
CA2696209C (en) 2007-08-14 2016-10-25 Fred Hutchinson Cancer Research Center Needle array assembly and method for delivering therapeutic agents
WO2009085969A2 (en) 2007-12-19 2009-07-09 Regenerative Sciences, Llc Compositions and methods to promote implantation and engrafment of stem cells
EP2227263A2 (de) * 2007-12-28 2010-09-15 Kuros Biosurgery AG In fibrinschaum integrierte pdgf-fusionsproteine
CN102325536A (zh) 2008-12-05 2012-01-18 再生科学有限责任公司 促进无血管组织修复的方法和组合物
US9113950B2 (en) * 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
ES2882852T3 (es) 2011-03-16 2021-12-02 Kuros Biosurgery Ag Formulación farmacéutica para la utilización en la fusión espinal
US20130071360A1 (en) 2011-06-29 2013-03-21 Biorestorative Therapies, Inc. Brown Fat Cell Compositions and Methods
SG11201401851UA (en) 2011-10-28 2014-05-29 Presage Biosciences Inc Methods for drug delivery
CN114480267A (zh) * 2022-01-21 2022-05-13 济南万泉生物技术有限公司 TGF-β2与Val混合刺激因子促进间充质干细胞表达更多细胞外基质

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
WO1994016720A1 (en) * 1993-01-26 1994-08-04 Celtrix Pharmaceuticals, Inc. COMPOSITIONS CONTAINING TRANSFORMING GROWTH FACTOR β STABILIZED BY GLYCOSAMINOGLYCANS

Also Published As

Publication number Publication date
EP0732105B1 (de) 2003-08-27
CA2165727A1 (en) 1996-09-17
EP0732105A3 (de) 1999-02-24
US5693341A (en) 1997-12-02
JPH08253429A (ja) 1996-10-01
ATE247982T1 (de) 2003-09-15
EP0732105A2 (de) 1996-09-18

Similar Documents

Publication Publication Date Title
DE69629610D1 (de) Affinitätsgebunden Collagenmatrizen für Wirkstoffabgabe
MX9603570A (es) Metodo y composiciones para incrementar la vida media en suero de agentes farmacologicamente activos.
EP1336600A3 (de) Dimer-selektive rxr Modulatoren und Verfahren zu ihrer Verwendung
BR9508402A (pt) Ligante de união construção de fator de tecido composição farmacêutica kit e uso de um ligante de união
AU5437590A (en) Method for enhancing transmembrane transport of exogenous molecules
ATE332918T1 (de) Neoglycoproteine
SE9704546D0 (sv) Novel compounds
EP0991618A4 (de) Selektive analoge der thyroidhormone
FI884051A0 (fi) Menetelmä stabiloitujen humaaniproteiinivalmisteiden valmistamiseksi
ID28003A (id) Turunan-turunan adamantana
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
HUT56583A (en) Process for producing peptide derivatives and pharmaceutical and diagnostic compositions comprising such compounds
EP1746160A3 (de) Hepatozyt-Wachstumsfaktor-Rezeptor-Antagonisten und deren Anwendung
DE69616523D1 (de) Verfahren zur baladung von lipidvesikeln
BR9501319A (pt) Composição tópica cosmetica e/ou dermatológica utilização desta composição e processo de tratamento cosmético
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
DE3868076D1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und diese derivate als aktive bestandteile enthaltende fungizide.
GR890100846A (el) Μεθοδος μετατροπης κυτταρικης διαφοροποιησης και λειτουργιας καισυνθεσεις της.
IL143706A0 (en) Polyol/oil suspensions for the sustained release of proteins
DE69425356T2 (de) Pro-Prodrugs, ihre Herstellung und Anwendung
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE69840150D1 (de) Verfahren, basierend auf affinitätskreuzbindung, der interaktion von biologisch aktiven peptiden an antikörper
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE68900029D1 (de) Pyrazolderivate, verfahren zu ihrer herstellung und diese derivate als aktive komponente enthaltende insektizide, mitizide und fungizide zusammensetzungen.

Legal Events

Date Code Title Description
8332 No legal effect for de